INTERNATIONAL PATENT: BIOLINERX LTD. FILES APPLICATION FOR "UNIT DOSAGE FORMS AND METHODS COMPRISING BL8040 FOR INTRAVENOUS ADMINISTRATION"

GENEVA, Feb. 17 -- BIOLINERX LTD. (2 HaMaAyan Street7177871 ModiIn) filed a patent application (PCT/IL2024/050748) for "UNIT DOSAGE FORMS AND METHODS COMPRISING BL8040 FOR INTRAVENOUS ADMINISTRATION" on Jul 29, 2024. With publication no. WO/2025/032571, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SORANI, Ella (2 Ha Kinor Street6092000 Kadima), HALBFINGER, Efrat (10 Ben Yehuda Street4322705 RaAnana)

Abstract: A unit dosage form comprising a peptide as set forth in SEQ ID NO: 1 (BL-8040) and a carrier is provided, wh...